Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Kirsten S. Evonuk; Carson E. Moseley; Ryan E. Doyle; Casey T. Weaver; Tara M. DeSilva

doi:10.3791/54348

ジャーナル

/

免疫学と感染

/

自己免疫性脱髄に薬理学的介入のためのCNS保護に対する免疫系の抑制を決定します

JoVE Journal
免疫学と感染

This content is Free Access.

JoVE Journal 免疫学と感染

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

自己免疫性脱髄に薬理学的介入のためのCNS保護に対する免疫系の抑制を決定します

Please note that all translations are automatically generated. Click here for the English version.

12,055 Views

•

09:38 min

•

September 12, 2016

DOI:

10.3791/54348-v

DOI:

10.3791/54348-v

•

09:38 min

September 12, 2016

•

4 Views

Kirsten S. Evonuk*¹, Carson E. Moseley*², Ryan E. Doyle¹, Casey T. Weaver², Tara M. DeSilva^1,3,4

¹Physical Medicine and Rehabilitation,University of Alabama at Birmingham, ²病理学科,University of Alabama at Birmingham, ³Department of Neurobiology,University of Alabama at Birmingham, ⁴Center for Glial Biology and Medicine,University of Alabama at Birmingham

筆記録

概要

This protocol describes how to determine whether pharmacological treatments for experimental autoimmune encephalomyelitis show CNS protection as a consequence of suppressing immune cell infiltration or are neuroprotective during the onslaught of immune cell infiltration.